<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Supplementary Material</title>
    <style>
        body {
            font-family: 'Helvetica Neue', Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f9f9f9;
            color: #333;
        }
        header {
            background-color: #3A4D42;
            color: #fff;
            padding: 20px;
            text-align: center;
        }
        h1 {
            margin: 0;
            font-size: 24px;
        }
        .container {
            padding: 20px;
        }
        h2 {
            color: #3A4D42;
            border-bottom: 2px solid #415942;
            padding-bottom: 5px;
            font-size: 20px;
        }
        p {
            font-size: 14px;
            line-height: 1.6;
        }
        .pdf-section {
            margin-bottom: 40px;
            text-align: center;
        }
        .download-button {
            display: inline-block;
            padding: 10px 20px;
            margin-bottom: 10px;
            background-color: #415942;
            color: #fff;
            text-decoration: none;
            border-radius: 5px;
            transition: background-color 0.3s ease;
            font-size: 16px;
        }
        .download-button:hover {
            background-color: #61805B;
        }
        .pdf-container {
            position: relative;
            width: 100%;
            padding-top: 75%; /* 4:3 Aspect Ratio */
            margin-bottom: 20px;
        }
        .pdf-container iframe {
            position: absolute;
            top: 0;
            left: 0;
            width: 100%;
            height: 100%;
            border: none;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: 40px;
            background-color: #fff;
            overflow-x: auto;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 8px 12px;
            text-align: left;
            vertical-align: top;
            font-size: 14px;
        }
        th {
            background-color: #415942;
            color: #fff;
        }
        tr:nth-child(even) {
            background-color: #f2f2f2;
        }
        .references {
            list-style-type: decimal;
            padding-left: 20px;
            font-size: 14px;
        }
        .reference-item {
            margin-bottom: 10px;
        }
        footer {
            background-color: #3A4D42;
            color: #fff;
            text-align: center;
            padding: 10px;
            position: relative;
            font-size: 14px;
        }
        /* Responsive Tables */
        @media (max-width: 768px) {
            h1 {
                font-size: 20px;
            }
            h2 {
                font-size: 18px;
            }
            p, th, td, .download-button, footer {
                font-size: 12px;
            }
            .pdf-container {
                padding-top: 56.25%; /* 16:9 Aspect Ratio */
            }
            .download-button {
                padding: 8px 16px;
                font-size: 14px;
            }
            .pdf-container iframe {
                height: 100%;
            }
            table {
                display: block;
                overflow-x: auto;
                white-space: nowrap;
            }
        }
    </style>
</head>
<body>

    <header>
        <h1>Supplementary Materials</h1>
    </header>

    <div class="container">
        <!-- Embed PDF Section -->
        <div class="pdf-section">
            <a href="Poster.pdf" class="download-button" download>Download PDF</a>
            <div class="pdf-container">
                <iframe src="Poster.pdf" title="Supplemental Poster PDF">
                    This browser does not support PDFs. Please download the PDF to view it: <a href="Poster.pdf">Download PDF</a>.
                </iframe>
            </div>
        </div>
        <!-- Supplemental Tables -->

        <!-- Supplemental Table 1 -->
        <h2>Supplemental Table 1: Stats by Video Category</h2>
        <p>
            This table provides statistics by video category, including the number of videos (N), total views, likes, and comments.
        </p>
        <table>
            <thead>
                <tr>
                    <th>Video Category</th>
                    <th>N</th>
                    <th>Views (millions)</th>
                    <th>Likes (thousands)</th>
                    <th>Comments (thousands)</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Created by general user</td>
                    <td>73</td>
                    <td>71m (71)</td>
                    <td>15,197k (48)</td>
                    <td>85k (35)</td>
                </tr>
                <tr>
                    <td>Mentions side effects/toxicity</td>
                    <td>67</td>
                    <td>81m (82)</td>
                    <td>14,977k (47)</td>
                    <td>93k (38)</td>
                </tr>
                <tr>
                    <td>Mentions personal sertraline use</td>
                    <td>55</td>
                    <td>52m (53)</td>
                    <td>13,462k (42)</td>
                    <td>62k (26)</td>
                </tr>
                <tr>
                    <td>Used music</td>
                    <td>54</td>
                    <td>50m (50)</td>
                    <td>3,126k (10)</td>
                    <td>59k (24)</td>
                </tr>
                <tr>
                    <td>Presents sertraline negatively</td>
                    <td>47</td>
                    <td>55m (56)</td>
                    <td>13,432k (42)</td>
                    <td>63k (26)</td>
                </tr>
                <tr>
                    <td>Used humor</td>
                    <td>42</td>
                    <td>47m (47)</td>
                    <td>4,067k (13)</td>
                    <td>47k (20)</td>
                </tr>
                <tr>
                    <td>Presents sertraline positively</td>
                    <td>38</td>
                    <td>43m (43)</td>
                    <td>2,389k (7)</td>
                    <td>60k (25)</td>
                </tr>
                <tr>
                    <td>Mentions efficacy and outcomes</td>
                    <td>26</td>
                    <td>47m (47)</td>
                    <td>2,426k (8)</td>
                    <td>59k (25)</td>
                </tr>
                <tr>
                    <td>Mentions depression</td>
                    <td>23</td>
                    <td>41m (42)</td>
                    <td>1,885k (6)</td>
                    <td>56k (23)</td>
                </tr>
                <tr>
                    <td>Mentions before/after results</td>
                    <td>19</td>
                    <td>15m (15)</td>
                    <td>700k (2)</td>
                    <td>18k (8)</td>
                </tr>
                <tr>
                    <td>Mentions anxiety</td>
                    <td>18</td>
                    <td>29m (29)</td>
                    <td>1,093k (3)</td>
                    <td>42k (17)</td>
                </tr>
                <tr>
                    <td>Shows sertraline or packaging</td>
                    <td>18</td>
                    <td>23m (23)</td>
                    <td>753k (2)</td>
                    <td>29k (12)</td>
                </tr>
                <tr>
                    <td>Created by medical professional</td>
                    <td>17</td>
                    <td>28m (29)</td>
                    <td>760k (2)</td>
                    <td>36k (15)</td>
                </tr>
                <tr>
                    <td>Mentions dose, frequency, timing</td>
                    <td>17</td>
                    <td>19m (19)</td>
                    <td>595k (2)</td>
                    <td>27k (11)</td>
                </tr>
                <tr>
                    <td>Mentions user credentials</td>
                    <td>14</td>
                    <td>22m (22)</td>
                    <td>621k (2)</td>
                    <td>28k (12)</td>
                </tr>
                <tr>
                    <td>Mentions sexual side effects</td>
                    <td>14</td>
                    <td>24m (24)</td>
                    <td>1,796k (6)</td>
                    <td>23k (10)</td>
                </tr>
                <tr>
                    <td>Mentions sertraline mechanism</td>
                    <td>14</td>
                    <td>24m (24)</td>
                    <td>679k (2)</td>
                    <td>33k (14)</td>
                </tr>
                <tr>
                    <td>Video in Spanish</td>
                    <td>13</td>
                    <td>13m (13)</td>
                    <td>551k (2)</td>
                    <td>16k (7)</td>
                </tr>
                <tr>
                    <td>Mentions OCD</td>
                    <td>8</td>
                    <td>17m (17)</td>
                    <td>595k (2)</td>
                    <td>24k (10)</td>
                </tr>
                <tr>
                    <td>Mentions GAD</td>
                    <td>7</td>
                    <td>10m (11)</td>
                    <td>415k (1)</td>
                    <td>12k (5)</td>
                </tr>
                <tr>
                    <td>Mentions receiving prescription</td>
                    <td>7</td>
                    <td>8m (8)</td>
                    <td>134k (0)</td>
                    <td>14k (6)</td>
                </tr>
                <tr>
                    <td>Mentions video sources</td>
                    <td>6</td>
                    <td>5m (5)</td>
                    <td>163k (1)</td>
                    <td>9k (4)</td>
                </tr>
                <tr>
                    <td>Mentions PTSD</td>
                    <td>6</td>
                    <td>14m (15)</td>
                    <td>495k (2)</td>
                    <td>17k (7)</td>
                </tr>
                <tr>
                    <td>Mentions premenstrual dysphoria</td>
                    <td>2</td>
                    <td>5m (5)</td>
                    <td>316k (1)</td>
                    <td>7k (3)</td>
                </tr>
                <tr>
                    <td>Mentions costs/insurance</td>
                    <td>2</td>
                    <td>0m (0)</td>
                    <td>15,977k (50)</td>
                    <td>121k (50)</td>
                </tr>
                <tr>
                    <td>Mentions psychotherapy</td>
                    <td>2</td>
                    <td>1m (1)</td>
                    <td>29k (0)</td>
                    <td>1k (0)</td>
                </tr>
                <tr>
                    <td>Mentions medication shortage</td>
                    <td>0</td>
                    <td>0m (0)</td>
                    <td>0k (0)</td>
                    <td>0k (0)</td>
                </tr>
            </tbody>
        </table>

        <!-- Supplemental Table 2 -->
        <h2>Supplemental Table 2: Breakdown by Video Creator Type</h2>
        <p>
            This table breaks down the content categories by video creator type, including metrics on views, likes, and comments along with their respective percentages.
        </p>
        <table>
            <thead>
                <tr>
                    <th>Content Category</th>
                    <th>N</th>
                    <th>Views (millions)</th>
                    <th>Views %</th>
                    <th>Likes (thousands)</th>
                    <th>Likes %</th>
                    <th>Comments (thousands)</th>
                    <th>Comments %</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Created by medical professional</td>
                    <td>17</td>
                    <td>28</td>
                    <td>29%</td>
                    <td>760</td>
                    <td>2%</td>
                    <td>36</td>
                    <td>15%</td>
                </tr>
                <tr>
                    <td>Mentions user credentials</td>
                    <td>14</td>
                    <td>22</td>
                    <td>22%</td>
                    <td>621</td>
                    <td>2%</td>
                    <td>28</td>
                    <td>12%</td>
                </tr>
                <tr>
                    <td>Created by general user</td>
                    <td>73</td>
                    <td>71</td>
                    <td>71%</td>
                    <td>15,197</td>
                    <td>48%</td>
                    <td>85</td>
                    <td>35%</td>
                </tr>
                <tr>
                    <td>Mentions video sources</td>
                    <td>6</td>
                    <td>5</td>
                    <td>5%</td>
                    <td>163</td>
                    <td>1%</td>
                    <td>9</td>
                    <td>4%</td>
                </tr>
                <tr>
                    <td>Video in Spanish</td>
                    <td>13</td>
                    <td>13</td>
                    <td>13%</td>
                    <td>551</td>
                    <td>2%</td>
                    <td>16</td>
                    <td>7%</td>
                </tr>
                <tr>
                    <td>Mentions personal sertraline use</td>
                    <td>55</td>
                    <td>52</td>
                    <td>53%</td>
                    <td>13,462</td>
                    <td>42%</td>
                    <td>62</td>
                    <td>26%</td>
                </tr>
                <tr>
                    <td>Mentions depression</td>
                    <td>23</td>
                    <td>41</td>
                    <td>42%</td>
                    <td>1,885</td>
                    <td>6%</td>
                    <td>56</td>
                    <td>23%</td>
                </tr>
                <tr>
                    <td>Mentions anxiety</td>
                    <td>18</td>
                    <td>29</td>
                    <td>29%</td>
                    <td>1,093</td>
                    <td>3%</td>
                    <td>42</td>
                    <td>17%</td>
                </tr>
                <tr>
                    <td>Mentions OCD</td>
                    <td>8</td>
                    <td>17</td>
                    <td>17%</td>
                    <td>595</td>
                    <td>2%</td>
                    <td>24</td>
                    <td>10%</td>
                </tr>
                <tr>
                    <td>Mentions PTSD</td>
                    <td>6</td>
                    <td>14</td>
                    <td>15%</td>
                    <td>495</td>
                    <td>2%</td>
                    <td>17</td>
                    <td>7%</td>
                </tr>
                <tr>
                    <td>Mentions GAD</td>
                    <td>7</td>
                    <td>10</td>
                    <td>11%</td>
                    <td>415</td>
                    <td>1%</td>
                    <td>12</td>
                    <td>5%</td>
                </tr>
                <tr>
                    <td>Mentions premenstrual dysphoria</td>
                    <td>2</td>
                    <td>5</td>
                    <td>5%</td>
                    <td>316</td>
                    <td>1%</td>
                    <td>7</td>
                    <td>3%</td>
                </tr>
                <tr>
                    <td>Presents sertraline positively</td>
                    <td>38</td>
                    <td>43</td>
                    <td>43%</td>
                    <td>2,389</td>
                    <td>7%</td>
                    <td>60</td>
                    <td>25%</td>
                </tr>
                <tr>
                    <td>Presents sertraline negatively</td>
                    <td>47</td>
                    <td>55</td>
                    <td>56%</td>
                    <td>13,432</td>
                    <td>42%</td>
                    <td>63</td>
                    <td>26%</td>
                </tr>
                <tr>
                    <td>Mentions side effects/toxicity</td>
                    <td>67</td>
                    <td>81</td>
                    <td>82%</td>
                    <td>14,977</td>
                    <td>47%</td>
                    <td>93</td>
                    <td>38%</td>
                </tr>
                <tr>
                    <td>Mentions sexual side effects</td>
                    <td>14</td>
                    <td>24</td>
                    <td>24%</td>
                    <td>1,796</td>
                    <td>6%</td>
                    <td>23</td>
                    <td>10%</td>
                </tr>
                <tr>
                    <td>Shows sertraline or packaging</td>
                    <td>18</td>
                    <td>23</td>
                    <td>23%</td>
                    <td>753</td>
                    <td>2%</td>
                    <td>29</td>
                    <td>12%</td>
                </tr>
                <tr>
                    <td>Mentions efficacy and outcomes</td>
                    <td>26</td>
                    <td>47</td>
                    <td>47%</td>
                    <td>2,426</td>
                    <td>8%</td>
                    <td>59</td>
                    <td>25%</td>
                </tr>
                <tr>
                    <td>Mentions receiving prescription</td>
                    <td>7</td>
                    <td>8</td>
                    <td>8%</td>
                    <td>134</td>
                    <td>0%</td>
                    <td>14</td>
                    <td>6%</td>
                </tr>
                <tr>
                    <td>Mentions sertraline mechanism</td>
                    <td>14</td>
                    <td>24</td>
                    <td>24%</td>
                    <td>679</td>
                    <td>2%</td>
                    <td>33</td>
                    <td>14%</td>
                </tr>
                <tr>
                    <td>Mentions before/after results</td>
                    <td>19</td>
                    <td>15</td>
                    <td>15%</td>
                    <td>700</td>
                    <td>2%</td>
                    <td>18</td>
                    <td>8%</td>
                </tr>
                <tr>
                    <td>Mentions dose, frequency, timing</td>
                    <td>17</td>
                    <td>19</td>
                    <td>19%</td>
                    <td>595</td>
                    <td>2%</td>
                    <td>27</td>
                    <td>11%</td>
                </tr>
                <tr>
                    <td>Mentions costs/insurance</td>
                    <td>2</td>
                    <td>0</td>
                    <td>0%</td>
                    <td>15,977</td>
                    <td>50%</td>
                    <td>121</td>
                    <td>50%</td>
                </tr>
                <tr>
                    <td>Mentions psychotherapy</td>
                    <td>2</td>
                    <td>1</td>
                    <td>1%</td>
                    <td>29</td>
                    <td>0%</td>
                    <td>1</td>
                    <td>0%</td>
                </tr>
                <tr>
                    <td>Mentions medication shortage</td>
                    <td>0</td>
                    <td>0</td>
                    <td>0%</td>
                    <td>0</td>
                    <td>0%</td>
                    <td>0</td>
                    <td>0%</td>
                </tr>
                <tr>
                    <td>Used music</td>
                    <td>54</td>
                    <td>50</td>
                    <td>50%</td>
                    <td>3,126</td>
                    <td>10%</td>
                    <td>59</td>
                    <td>24%</td>
                </tr>
                <tr>
                    <td>Used humor</td>
                    <td>42</td>
                    <td>47</td>
                    <td>47%</td>
                    <td>4,067</td>
                    <td>13%</td>
                    <td>47</td>
                    <td>20%</td>
                </tr>
            </tbody>
        </table>

        <!-- You can keep or remove the existing tables below as needed -->

        <!-- References -->
            <!-- References -->
        <h2>References</h2>
        <ol class="references">
            <li class="reference-item">Mental Illness - National Institute of Mental Health (NIMH). Accessed August 16, 2024. <a href="https://www.nimh.nih.gov/health/statistics/mental-illness" target="_blank">https://www.nimh.nih.gov/health/statistics/mental-illness</a></li>
            <li class="reference-item">Ceci L. Global TikTok user age and gender distribution 2024. Statista. Accessed August 16, 2024. <a href="https://www.statista.com/statistics/1299771/tiktok-global-user-age-distribution/" target="_blank">https://www.statista.com/statistics/1299771/tiktok-global-user-age-distribution/</a></li>
            <li class="reference-item">Zheluk A, Anderson J, Dineen-Griffin S. Analysis of Acute Non-specific Back Pain Content on TikTok: An Exploratory Study. Cureus. 2022;14(1):e21404. doi:<a href="https://doi.org/10.7759/cureus.21404" target="_blank">10.7759/cureus.21404</a></li>
            <li class="reference-item">McBriar JD, Mishra A, Shah HA, Boockvar JA, Langer DJ, D’Amico RS. #Neurosurgery: A Cross-Sectional Analysis of Neurosurgical Content on TikTok. World Neurosurg X. 2023;17:100137. doi:<a href="https://doi.org/10.1016/j.wnsx.2022.100137" target="_blank">10.1016/j.wnsx.2022.100137</a></li>
            <li class="reference-item">Aghajani MJ, Aghajani R. TikTok and #psoriasis: A cross-sectional study of content quality. Australas J Dermatol. 2023;64(4):e369-e371. doi:<a href="https://doi.org/10.1111/ajd.14149" target="_blank">10.1111/ajd.14149</a></li>
            <li class="reference-item">Basch CH, Narayanan S, Tang H, Fera J, Basch CE. Descriptive analysis of TikTok videos posted under the hashtag #Ozempic. Journal of Medicine, Surgery, and Public Health. 2023;1:100013. doi:<a href="https://doi.org/10.1016/j.glmedi.2023.100013" target="_blank">10.1016/j.glmedi.2023.100013</a></li>
            <li class="reference-item">Arillotta D, Floresta G, Guirguis A, et al. GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain Sci. 2023;13(11):1503. doi:<a href="https://doi.org/10.3390/brainsci13111503" target="_blank">10.3390/brainsci13111503</a></li>
            <li class="reference-item">Goodwin RD, Dierker LC, Wu M, Galea S, Hoven CW, Weinberger AH. Trends in U.S. Depression Prevalence From 2015 to 2020: The Widening Treatment Gap. Am J Prev Med. 2022;63(5):726-733. doi:<a href="https://doi.org/10.1016/j.amepre.2022.05.014" target="_blank">10.1016/j.amepre.2022.05.014</a></li>
            <li class="reference-item">Bishop M. Healthcare Social Media for Consumer Informatics. In: Edmunds M, Hass C, Holve E, eds. Consumer Informatics and Digital Health: Solutions for Health and Health Care. Springer International Publishing; 2019:61-86. doi:<a href="https://doi.org/10.1007/978-3-319-96906-0_4" target="_blank">10.1007/978-3-319-96906-0_4</a></li>
            <li class="reference-item">Burstin H, Curry S, Ranney ML, et al. Identifying Credible Sources of Health Information in Social Media: Phase 2—Considerations for Non-Accredited Nonprofit Organizations, For-Profit Entities, and Individual Sources. NAM Perspectives. Published online May 23, 2023. doi:<a href="https://doi.org/10.31478/202305b" target="_blank">10.31478/202305b</a></li>
            <li class="reference-item">de Anta L, Alvarez-Mon MA, Ortega MA, et al. Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study. J Pers Med. 2022;12(2):155. doi:<a href="https://doi.org/10.3390/jpm12020155" target="_blank">10.3390/jpm12020155</a></li>
            <li class="reference-item">Malla A, Gold I. Public discourse on mental health: a critical view. J Psychiatry Neurosci. 2024;49(2):E126-E131. doi:<a href="https://doi.org/10.1503/jpn.230161" target="_blank">10.1503/jpn.230161</a></li>
            <li class="reference-item">Kreps GL. Promoting patient comprehension of relevant health information. Isr J Health Policy Res. 2018;7:56. doi:<a href="https://doi.org/10.1186/s13584-018-0250-z" target="_blank">10.1186/s13584-018-0250-z</a></li>
            <li class="reference-item">Korshakova E, Marsh JK, Kleinberg S. Health Information Sourcing and Health Knowledge Quality: Repeated Cross-sectional Survey. JMIR Form Res. 2022;6(9):e39274. doi:<a href="https://doi.org/10.2196/39274" target="_blank">10.2196/39274</a></li>
            <li class="reference-item">Inc G. U.S. Depression Rates Reach New Highs. Gallup.com. May 17, 2023. Accessed June 22, 2024. <a href="https://news.gallup.com/poll/505745/depression-rates-reach-new-highs.aspx" target="_blank">https://news.gallup.com/poll/505745/depression-rates-reach-new-highs.aspx</a></li>
            <li class="reference-item">Howarth J. TikTok User Age, Gender, & Demographics (2024). Exploding Topics. October 12, 2022. Accessed June 22, 2024. <a href="https://explodingtopics.com/blog/tiktok-demographics" target="_blank">https://explodingtopics.com/blog/tiktok-demographics</a></li>
            <li class="reference-item">Antidepressant Use On the Rise Among Young Adults, Adolescents. Healthline. February 27, 2024. Accessed June 22, 2024. <a href="https://www.healthline.com/health-news/antidepressant-prescriptions-increasing-young-people" target="_blank">https://www.healthline.com/health-news/antidepressant-prescriptions-increasing-young-people</a></li>
            <li class="reference-item">Singh HK, Saadabadi A. Sertraline. In: StatPearls. StatPearls Publishing; 2024. Accessed June 20, 2024. <a href="http://www.ncbi.nlm.nih.gov/books/NBK547689/" target="_blank">http://www.ncbi.nlm.nih.gov/books/NBK547689/</a></li>
            <li class="reference-item">Backlinko Team. TikTok Statistics You Need to Know in 2024. Backlinko. December 11, 2023. Accessed June 20, 2024. <a href="https://backlinko.com/tiktok-users" target="_blank">https://backlinko.com/tiktok-users</a></li>
            <li class="reference-item">Chua KP, Volerman A, Zhang J, Hua J, Conti RM. Antidepressant Dispensing to US Adolescents and Young Adults: 2016–2022. Pediatrics. 2024;153(3):e2023064245. doi:<a href="https://doi.org/10.1542/peds.2023-064245" target="_blank">10.1542/peds.2023-064245</a></li>
            <li class="reference-item">Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. In: StatPearls. StatPearls Publishing; 2024. Accessed June 20, 2024. <a href="http://www.ncbi.nlm.nih.gov/books/NBK554406/" target="_blank">http://www.ncbi.nlm.nih.gov/books/NBK554406/</a></li>
            <li class="reference-item">Chen J, Wang Y. Social Media Use for Health Purposes: Systematic Review. J Med Internet Res. 2021;23(5):e17917. doi:<a href="https://doi.org/10.2196/17917" target="_blank">10.2196/17917</a></li>
            <li class="reference-item">Ceci. Number of U.S. TikTok users 2027. Statista. Accessed June 20, 2024. <a href="https://www.statista.com/statistics/1100836/number-of-us-tiktok-users/" target="_blank">https://www.statista.com/statistics/1100836/number-of-us-tiktok-users/</a></li>
            <li class="reference-item">Top 10 most common antidepressants | Definitive Healthcare. Accessed June 20, 2024. <a href="https://www.definitivehc.com/resources/healthcare-insights/top-antidepressants-by-prescription-volume" target="_blank">https://www.definitivehc.com/resources/healthcare-insights/top-antidepressants-by-prescription-volume</a></li>
            <li class="reference-item">What Is Depression? Accessed June 18, 2024. <a href="https://www.psychiatry.org:443/patients-families/depression/what-is-depression" target="_blank">https://www.psychiatry.org:443/patients-families/depression/what-is-depression</a></li>
            <li class="reference-item">Goodwin RD, Dierker LC, Wu M, Galea S, Hoven CW, Weinberger AH. Trends in U.S. Depression Prevalence From 2015 to 2020: The Widening Treatment Gap. Am J Prev Med. 2022;63(5):726-733. doi:<a href="https://doi.org/10.1016/j.amepre.2022.05.014" target="_blank">10.1016/j.amepre.2022.05.014</a></li>
            <li class="reference-item">Administration SA and MHS. Table 9, DSM-IV to DSM-5 Major Depressive Episode/Disorder Comparison. June 2016. Accessed June 18, 2024. <a href="https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t5/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t5/</a></li>
            <li class="reference-item">Major Depression - National Institute of Mental Health (NIMH). Accessed June 18, 2024. <a href="https://www.nimh.nih.gov/health/statistics/major-depression" target="_blank">https://www.nimh.nih.gov/health/statistics/major-depression</a></li>
        </ol>
    </div>

    <footer>
        &copy; Descriptive Analysis of TikTok Videos Under the Hashtag #Sertraline: Insights for Healthcare Providers
    </footer>

</body>
</html>
